Neurocrine Biosciences

NBIX · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reports earnings in about 1 month

Previous year: $1.08B

+37.6%

Total Assets

$4.63B

Previous year: $3.72B

+24.5%

Loading...

Neurocrine Biosciences

Unlock previous datapoints

Upgrade

Neurocrine Biosciences

Unlock previous datapoints

Upgrade

Neurocrine Biosciences Revenue by Segment

Revenue by Segment

INGREZZA Net Product Sales Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

CRENESSITY Net Product Sales Revenue

CapyFin.com

Other Revenues Revenue

CapyFin.com

Collaboration Revenues Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$12.8B

P/E Ratio

20.72

Sector

N/A

Industry

N/A

52-Week High

$155

52-Week Low

$87.4

GAAP R&D Expense

$258M

Non-GAAP R&D Expense

$234M

GAAP SG&A Expense

$302M

Non-GAAP SG&A Expense

$266M

Acquired In-Process R&D

$17M

Products

Get in Touch

Resources

Neurocrine Biosciences

Neurocrine Biosciences

Neurocrine Biosciences

Neurocrine Biosciences Revenue by Segment

Revenue by Segment

INGREZZA Net Product Sales Revenue

CRENESSITY Net Product Sales Revenue

Other Revenues Revenue

Collaboration Revenues Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics